Published in J Pharm Sci on April 01, 1995
Discovery pharmaceutics--challenges and opportunities. AAPS J (2006) 0.83
Study on Mixed Solvency Concept in Formulation Development of Aqueous Injection of Poorly Water Soluble Drug. J Pharm (Cairo) (2013) 0.77
[The female sex and mortality after acute myocardial infarct]. Rev Esp Cardiol (1993) 2.44
A novel thermogravimetric method for estimating the saturated vapor pressure of low-volatility compounds. J Pharm Sci (1998) 1.61
Solubilization of ionized and un-ionized flavopiridol by ethanol and polysorbate 20. J Pharm Sci (1999) 1.53
Emergency coronary artery bypass grafting (CABG) after failed coronary artery intervention--caution regarding the combined use of aspirin, ticlopidine and abciximab. Aust N Z J Med (1998) 1.39
Intra-aortic balloon rupture. An increasing trend? ASAIO J (1993) 1.39
[The clinical characteristics of pulmonary tuberculosis in the elderly]. An Med Interna (1997) 1.38
Estimation of the aqueous solubility I: application to organic nonelectrolytes. J Pharm Sci (2001) 1.23
Solubility and partitioning VI: octanol solubility and octanol-water partition coefficients. J Pharm Sci (1983) 1.22
Solubilization of rapamycin. Int J Pharm (2001) 1.17
Human T cell growth factor. I. Optimal conditions for its production. J Immunol (1979) 1.17
Cytotoxic activities of normal cultured human T cells. J Immunol (1978) 1.12
Solubility and partitioning I: Solubility of nonelectrolytes in water. J Pharm Sci (1980) 1.11
Influence of acute-phase parasite load on pathology, parasitism, and activation of the immune system at the late chronic phase of Chagas' disease. Infect Immun (1999) 1.08
Identification of quantitative trait loci involved in fruit quality traits in melon (Cucumis melo L.). Theor Appl Genet (2003) 1.08
Combined effect of cosolvent and cyclodextrin on solubilization of nonpolar drugs. J Pharm Sci (1999) 1.07
Ig-isotype patterns of primary and secondary B cell responses to Plasmodium chabaudi chabaudi correlate with IFN-gamma and IL-4 cytokine production with CD45RB expression by CD4+ spleen cells. Scand J Immunol (1996) 1.03
Enhanced intestinal absorption of cyclosporine in rats through the reduction of emulsion droplet size. Pharm Res (1989) 1.02
Solubilization of fluasterone. J Pharm Sci (1999) 0.99
IFN-gamma, but not nitric oxide or specific IgG, is essential for the in vivo control of low-virulence Sylvio X10/4 Trypanosoma cruzi parasites. Scand J Immunol (2007) 0.98
Insulin regulation of insulin-like growth factor action in rat hepatoma cells. J Biol Chem (1984) 0.97
Rationale for design of biologically reversible drug derivatives: prodrugs. J Pharm Sci (1975) 0.97
Solubility of nonelectrolytes in polar solvents II: solubility of aliphatic alcohols in water. J Pharm Sci (1974) 0.97
Solubility of nonelectrolytes in polar solvents IV: nonpolar drugs in mixed solvents. J Pharm Sci (1976) 0.96
Prediction of aqueous solubility of organic compounds by the general solubility equation (GSE). J Chem Inf Comput Sci (2001) 0.96
Dyspnea after pneumonectomy: the result of an atrial septal defect. Ann Thorac Surg (1997) 0.95
Solubilization of cyclosporin A. AAPS PharmSciTech (2001) 0.95
Susceptibility of the different developmental stages of the asexual (schizogonic) erythrocyte cycle of Plasmodium chabaudi chabaudi to hyperimmune serum, immunoglobulin (Ig)G1, IgG2a and F(ab')2 fragments. Parasite Immunol (2001) 0.94
Mass transport phenomena and models: theoretical concepts. J Pharm Sci (1974) 0.93
Solubilization by cosolvents I: organic solutes in propylene glycol-water mixtures. J Pharm Sci (1985) 0.93
Physicochemical properties of prostaglandin F2 alpha (tromethamine salt): solubility behavior, surface properties, and ionization constants. J Pharm Sci (1973) 0.93
A new parenteral vehicle for the administration of some poorly water soluble anti-cancer drugs. J Parenter Sci Technol (1987) 0.88
Most parasite-specific CD8+ cells in Trypanosoma cruzi-infected chronic mice are down-regulated for T-cell receptor-alphabeta and CD8 molecules. Immunology (2001) 0.87
Solubilization of NSC-639829. Int J Pharm (2001) 0.87
Formulation and in vivo evaluation of ocular insert containing phenylephrine and tropicamide. Int J Pharm (1999) 0.87
Solubility of organic solutes in ethanol/water mixtures. J Pharm Sci (1994) 0.86
Combined effect of complexation and pH on solubilization. J Pharm Sci (1998) 0.86
A new parenteral emulsion for the administration of taxol. Pharm Res (1987) 0.86
Lysis of human red blood cells. 4. Comparison of in vitro and in vivo hemolysis data. J Pharm Sci (1997) 0.86
Relationship between polysorbate 80 solubilization descriptors and octanol-water partition coefficients of drugs. Int J Pharm (2000) 0.86
Solubility of nonelectrolytes in polar solvents III: Alkyl p-aminobenzoates in polar and mixed solvents. J Pharm Sci (1975) 0.84
Solubilization of flavopiridol by pH control combined with cosolvents, surfactants, or complexants. J Pharm Sci (1999) 0.84
Correlation between log P and ClogP for some steroids. J Pharm Sci (1997) 0.84
Prediction of drug solubility by the general solubility equation (GSE). J Chem Inf Comput Sci (2001) 0.84
Melting point, boiling point, and symmetry. Pharm Res (1990) 0.84
Lysis of human red blood cells 1: Effect of contact time on water induced hemolysis. PDA J Pharm Sci Technol (1996) 0.83
Characterization of the spleen B-cell compartment at the early and late blood-stage Plasmodium chabaudi malaria. Scand J Immunol (2007) 0.83
Zinc transformations in acidic soil and zinc efficiency on maize by adding six organic zinc complexes. J Agric Food Chem (2002) 0.83
Lysis of human red blood cells. 3: Effect of contact time on surfactant-induced hemolysis. PDA J Pharm Sci Technol (1998) 0.83
Pyrene-labeled DNA probes for homogeneous detection of complementary DNA sequences: poly(C) model system. Anal Biochem (1996) 0.82
Solubility and partitioning. VII: Solubility of barbiturates in water. J Pharm Sci (1987) 0.82
Specific binding of 3H-estradiol to rat prostate nuclear matrix. Biochem Biophys Res Commun (1985) 0.82
UPPER III: unified physical property estimation relationships. Application to non-hydrogen bonding aromatic compounds. J Pharm Sci (1999) 0.81
Solubility of nonelectrolytes in polar solvents. J Pharm Sci (1972) 0.81
A new mutant hairless mouse with lymph node hyperplasia and late onset of autoimmune pathology. Braz J Med Biol Res (1994) 0.81
Stabilization of eptifibatide by cosolvents. Int J Pharm (2001) 0.81
Use of pure t-butanol as a solvent for freeze-drying: a case study. Int J Pharm (2001) 0.80
Role of membrane-bound IgM in Trypanosoma cruzi evasion from immune clearance. J Parasitol (1997) 0.80
Letter: Influence of solute properties on release of p-aminobenzoic acid esters from silicone rubber: theoretical considerations. J Pharm Sci (1974) 0.80
Potentiometric titration of monomeric and micellar acylcarnitines. J Pharm Sci (1970) 0.80
A flat circular hole device for zero-order release of drugs: characterization of the moving dissolution boundary. Pharm Res (1990) 0.80
Multiple-hole approach to zero-order release. J Pharm Sci (1985) 0.80
Cosolvency and cosolvent polarity. Pharm Res (1987) 0.80
Studies in phlebitis. IV: Injection rate and amiodarone-induced phlebitis. J Parenter Sci Technol (1993) 0.80
Evaluation of in vitro precipitation methods. J Pharm Sci (1998) 0.79
Influence of the polyclonal activation induced by Plasmodium chabaudi on ongoing OVA-specific B- and T-cell responses. Scand J Immunol (2002) 0.79
Parenteral formulation of Flavopiridol (NSC-649890). PDA J Pharm Sci Technol (1997) 0.79
Behavior of zinc from six organic fertilizers applied to a navy bean crop grown in a calcareous soil. J Agric Food Chem (2007) 0.79
Solubility of fatty acids and other hydrophobic molecules in liquid trioleoylglycerol. J Lipid Res (1984) 0.79
Ocular devices for the controlled systemic delivery of insulin: in vitro and in vivo dissolution. Int J Pharm (1999) 0.79
Buffer capacity and precipitation control of pH solubilized phenytoin formulations. Int J Pharm (1999) 0.79
Solubilization of diazepam. PDA J Pharm Sci Technol (1998) 0.79
Ocular gelfoam disc-applicator for pupillary dilation in humans. J Ocul Pharmacol Ther (2000) 0.79
Emulsion formulations for intravenous administration of paclitaxel. PDA J Pharm Sci Technol (1998) 0.79
Lysis of human red blood cells in the presence of various cosolvents. III. The relationship between hemolytic potential and structure. J Parenter Sci Technol (1987) 0.78
Human interleukin 2: production by both TG cells and other T cells. Scand J Immunol (1981) 0.78
Some micellar properties of long-chain acylcarnitines. J Colloid Interface Sci (1970) 0.78
Solubility and partitioning IV: Aqueous solubility and octanol-water partition coefficients of liquid nonelectrolytes. J Pharm Sci (1981) 0.78
Multiple species of estrogen binding sites in the nuclear fraction of the rat prostate. Biochem Biophys Res Commun (1982) 0.78
Influence of thermal treatment on sequential extraction and leaching behaviour of trace metals in a contaminated sewage sludge. Bioresour Technol (2001) 0.78
Studies in phlebitis. VI: Dilution-induced precipitation of amiodarone HCL. J Parenter Sci Technol (1993) 0.78
A method for the rapid estimation of sublimation rates of organic compounds at standard temperature and pressure. J Pharm Sci (1997) 0.78
Systemic delivery of insulin via an enhancer-free ocular device. J Pharm Sci (1997) 0.78
Effect of formulation on the systemic absorption of insulin from enhancer-free ocular devices. Int J Pharm (1999) 0.78
Airway disorders and pulmonary function in snorers. A population-based study. Respir Med (2000) 0.78
Cloning and characterization of a type-A response regulator differentially expressed during adventitious shoot formation in Pinus pinea L. J Plant Physiol (2010) 0.77
Studies in phlebitis: detection and quantitation using a thermographic camera. Pharm Res (1991) 0.77
Controlled delivery of pilocarpine. 1. In vitro characterization of Gelfoam matrices. Pharm Res (1993) 0.77
Evaluation of intravenous flavopiridol formulations. PDA J Pharm Sci Technol (2000) 0.77
Ocular device for the controlled systemic delivery of insulin. J Pharm Sci (1996) 0.77
Ideal solubility of a solid solute: effect of heat capacity assumptions. Pharm Res (1992) 0.77
The preparation of soft gelatin capsules for a radioactive tracer study. Pharm Dev Technol (1999) 0.77
Systemic absorption of insulin from a Gelfoam ocular device. Int J Pharm (1999) 0.77
Effect of Brij-78 on systemic delivery of insulin from an ocular device. J Pharm Sci (1997) 0.77
Residual metabolism of the hypothermic-arrested pig heart. J Surg Res (1981) 0.76
Increase in XET activity in bean (Phaseolus vulgaris L.) cells habituated to dichlobenil. Planta (2007) 0.76
Partition coefficients and surface areas of some alkylbenzenes. J Med Chem (1976) 0.76
Transport of alkyl homologs across synthetic and biological membranes: a new model for chain length-activity relationships. J Pharm Sci (1973) 0.76
Effect of hydroxypropyl-beta-cyclodextrin and pH on the solubility of levemopamil HCl. J Pharm Sci (1998) 0.76
Comparison of two methods for predicting aqueous solubility. J Chem Inf Comput Sci (2001) 0.76